论文部分内容阅读
目的观察妇洁康洗剂治疗慢性盆腔炎的临床疗效。方法 120例慢性盆腔炎患者,随机分为治疗组与对照组,每组60例。对照组予以西医基础治疗及相关常规护理,治疗组在对照组治疗基础上加用妇洁康洗剂外洗,比较两组治疗前后临床疗效及肿瘤坏死因子-α(TNF-α)、白细胞介素-2(IL-2)、白细胞介素-4(IL-4)、白细胞介素-10(IL-10)指标水平变化。结果治疗组治愈率为41.67%,总有效率为96.67%,对照组治愈率为20.0%,总有效率为83.33%,比较差异有统计学意义(P<0.05)。治疗组患者治疗后血清TNF-α水平明显高于对照组,IL-2、IL-4和IL-10水平明显低于对照组(P<0.05)。与治疗组治疗前炎症因子水平比较,患者经治疗后血清TNF-α水平升高,IL-2、IL-4和IL-10水平显著降低(P<0.01)。结论妇洁康洗剂对慢性盆腔炎具有良好的临床疗效及较高的安全性。
Objective To observe the clinical efficacy of Fujie Kang Lotion in the treatment of chronic pelvic inflammatory disease. Methods 120 patients with chronic pelvic inflammatory disease were randomly divided into treatment group and control group, 60 cases in each group. The control group was treated with Western medicine and routine nursing. The treatment group was treated with Fujie Kang Lotion on the basis of the control group, and the clinical efficacy and the levels of tumor necrosis factor-α (TNF-α), leukocyte (IL-2), interleukin-4 (IL-4) and interleukin-10 (IL-10) Results The cure rate was 41.67% in the treatment group and the total effective rate was 96.67%. The cure rate in the control group was 20.0% and the total effective rate was 83.33%. The difference was statistically significant (P <0.05). The level of serum TNF-α in the treatment group was significantly higher than that in the control group, and the levels of IL-2, IL-4 and IL-10 in the treatment group were significantly lower than those in the control group (P <0.05). The level of serum TNF-α, IL-2, IL-4 and IL-10 in the treatment group were significantly lower than those in the treatment group before treatment (P <0.01). Conclusion Fu Jie Kang lotion on chronic pelvic inflammatory disease has a good clinical efficacy and high safety.